Our results showed that among the 8 candidate genes, the survival and prognosis of NSCLC patients with the seven high expression genes of CDK1, CCNB1, CCNA2, BIRC5, CCNB2, KIAA0101 and MELK were significantly worse (p < 0.01). This evidence concerns the gene MELK and non-small cell lung carcinoma.